Adaptive Biotechnologies Stock Target Price and Analyst Consensus
| ADPT Stock | USD 6.39 0.07 1.11% |
The current analyst and expert consensus on Adaptive Biotechnologies is Strong Buy, with 3 strong buy opinions. The current projected Adaptive Biotechnologies target price consensus is 12.14 with 8 analyst opinions. Check out Macroaxis Advice on Adaptive Biotechnologies to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Adaptive Biotechnologies analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Adaptive Biotechnologies executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Adaptive Biotechnologies. We strongly encourage you to use your own analysis of Adaptive Biotechnologies to validate this buy or sell advice. Adaptive Biotechnologies buy-or-sell recommendation module provides average expert sentiment on the projected Adaptive Biotechnologies target price to derive its highest and lowest estimates based on projected price volatility of 5.1611.
Lowest Forecast 11.05 | Highest Forecast 13.48 | Target Price 12.14 |
Adaptive |
It's important to approach Adaptive Biotechnologies' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Adaptive Biotechnologies price targets
Adaptive Biotechnologies' stock target price is an estimate of its future price, usually made by analysts. Using Adaptive Biotechnologies' target price to determine if it is a suitable investment can be done through the following steps:- Look at Adaptive Biotechnologies' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Adaptive Biotechnologies' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Adaptive Biotechnologies Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Adaptive Biotechnologies is a key component of Adaptive Biotechnologies valuation and have some predictive power on the future returns of a Adaptive Biotechnologies.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 40 shares | |
 | Momentum Invested over 50 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Millennials Best Invested few shares | |
 | Technology Invested few shares | |
 | Blockchain Invested few shares | |
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.